CASIDY ENFINGER: Open Payments
NPI 1386892446 · CAMILLA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 18 payments from 7 companies in 2025. Trend: 2023 $433 · 2024 $815 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Dexcom, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Ozempic, MOUNJARO, JARDIANCE, AIRSUPRA, Dexcom G6 Transmitter, Kerendia, BREZTRI, FARXIGA.
Industry payments across GA — which companies pay providers there.
